Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection

NCT03955172 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Failure and Rejection

Interventions

DRUG: Everolimus

Sponsor

Hospices Civils de Lyon